Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (12)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2020

  1. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

2019

  1. Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Supplementary data for the biological age linked to oxidative stress modifies breast cancer aggressiveness

    Data in Brief

  2. The biological age linked to oxidative stress modifies breast cancer aggressiveness

    Free Radical Biology and Medicine, Vol. 120, pp. 133-146

2017

  1. dIvergEnt: How IgE axis contributes to the continuum of allergic asthma and anti-IgE therapies

    International Journal of Molecular Sciences, Vol. 18, Núm. 6

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. Missing heritability of complex diseases: Enlightenment by genetic variants from intermediate phenotypes

    BioEssays, Vol. 38, Núm. 7, pp. 664-673

2015

  1. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

    Genome Biology, Vol. 16, Núm. 1